Tytuł pozycji:
Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer
-
Tytuł:
-
Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer
-
Autorzy:
-
Xu, YanAff1, Aff2, Aff3
Xiang, Zheng
Alnaggar, MohammedAff3, Aff8
Kouakanou, Léonce
Li, JiaweiAff2, Aff3
He, Junyi
Yang, Jiashuang
Hu, Yi
Chen, Yan
Lin, Li
Hao, JianleiAff2, Aff3
Li, Jingxia
Chen, Jibing
Li, Man
Wu, Qingling
Peters, Christian
Zhou, QinghuaAff2, Aff3
Li, JianshuangAff2, Aff3
Liang, Yingqing
Wang, Xiaohua
Han, Baohui
Ma, Meili
Kabelitz, Dieter
Xu, KechengAff3, Aff6
Tu, Wenwei
Wu, YangzheAff2, Aff3
Yin, ZhinanAff2, Aff3
-
Źródło:
-
Cellular & Molecular Immunology. 18(2):427-439
-
